Phase I Dose-Escalation (De) Trial Of High-Dose Melphalan (M) With Palifermin (P) For Cytoprotection Followed By Autologous Stem Cell Transplantation (Asct) For Myeloma (Mm) Patients With Abnormal Renal Function (Abrf)
JOURNAL OF CLINICAL ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要